2023-03-30T16:58:22+08:00 weekly 1.0 https://ro.prisysbiotech.com/ 2024-11-12T09:23:04+08:00 weekly 0.9 https://ro.prisysbiotech.com/animal-welfare 2024-11-12T09:23:18+08:00 weekly 0.9 https://ro.prisysbiotech.com/ophthalmic-disease-research 2024-11-12T09:23:16+08:00 weekly 0.9 https://ro.prisysbiotech.com/metabolic-syndromes-research 2024-11-12T09:23:25+08:00 weekly 0.9 https://ro.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-12T09:23:13+08:00 weekly 0.9 https://ro.prisysbiotech.com/hematological-disease-research 2024-11-12T09:23:15+08:00 weekly 0.9 https://ro.prisysbiotech.com/respiratory-disease-research 2023-03-31T10:50:30+08:00 weekly 0.9 https://ro.prisysbiotech.com/co-develop 2024-11-12T09:23:13+08:00 weekly 0.9 https://ro.prisysbiotech.com/inflammation-immunology-disorders 2024-11-12T09:23:04+08:00 weekly 0.9 https://ro.prisysbiotech.com/translational-research-center 2026-08-08T19:02:10+08:00 weekly 0.9 https://ro.prisysbiotech.com/download 2024-09-29T14:23:03+08:00 weekly 0.9 https://ro.prisysbiotech.com/fibrosis 2024-09-29T14:45:25+08:00 weekly 0.9 https://ro.prisysbiotech.com/nephrology 2024-11-12T09:23:06+08:00 weekly 0.9 https://ro.prisysbiotech.com/about-us 2024-11-12T09:23:03+08:00 weekly 0.9 https://ro.prisysbiotech.com/contact-us 2023-03-31T10:50:27+08:00 weekly 0.9 https://ro.prisysbiotech.com/newslist-1 2024-11-12T09:23:04+08:00 weekly 0.9 https://ro.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://ro.prisysbiotech.com/blog/ 2023-03-31T10:31:53+08:00 weekly 1.0 https://ro.prisysbiotech.com/nhp-pharmacology/ 2023-03-31T10:31:53+08:00 weekly 0.9 https://ro.prisysbiotech.com/translation-research/ 2023-03-31T10:31:54+08:00 weekly 0.9 https://ro.prisysbiotech.com/pk-pd-adme/ 2023-03-31T10:31:54+08:00 weekly 0.9 https://ro.prisysbiotech.com/safety-evaluation/ 2023-03-31T10:31:54+08:00 weekly 0.9 https://ro.prisysbiotech.com/biosafety-research/ 2024-04-10T12:09:47+08:00 weekly 0.9 https://ro.prisysbiotech.com/clearpoint/ 2023-03-31T10:50:20+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2023-03-31T10:50:19+08:00 weekly 0.8 https://ro.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-12T09:23:00+08:00 weekly 0.8 https://ro.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-12T09:23:21+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2026-08-13T17:50:43+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-12T09:22:58+08:00 weekly 0.8 https://ro.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-12T09:23:08+08:00 weekly 0.8 https://ro.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-31T10:50:26+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-03-31T10:50:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-12T09:22:57+08:00 weekly 0.8 https://ro.prisysbiotech.com/translation-research/nhpresources.html 2024-11-12T09:23:02+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-12T09:23:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-12T09:23:04+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-03-31T10:50:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-12T09:23:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-12T09:23:13+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-31T10:50:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-12T09:23:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-31T10:50:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-03-31T10:50:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-03-31T10:50:24+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-12T09:23:07+08:00 weekly 0.8 https://ro.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2023-03-31T10:50:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/translation-research/translational-studies.html 2024-11-12T09:23:04+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-12T09:23:13+08:00 weekly 0.8 https://ro.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-12T09:23:03+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-31T10:50:24+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-03-31T10:50:22+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-11-12T09:23:03+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2023-03-31T10:50:24+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-12T09:23:07+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2023-03-31T10:50:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-12T09:23:02+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2026-08-13T17:50:46+08:00 weekly 0.8 https://ro.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-12T09:23:08+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/pk-pd-adme/adme.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-12T09:23:08+08:00 weekly 0.8 https://ro.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-12T09:23:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-12T09:23:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-12T09:23:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-26T14:11:18+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-26T14:11:22+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-26T14:11:24+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-26T14:11:25+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-11-12T09:23:10+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-26T14:11:30+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-26T14:11:32+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-12-08T13:27:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-08T15:48:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-02T01:53:21+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-02T01:53:26+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-21T08:49:40+08:00 weekly 0.8 https://ro.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-07-21T10:03:49+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-08-23T21:24:42+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T20:46:28+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T21:24:02+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T16:02:19+08:00 weekly 0.8 https://ro.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-04T04:33:34+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T19:15:55+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T21:16:47+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-05-01T06:30:16+08:00 weekly 0.8 https://ro.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-05-01T06:30:13+08:00 weekly 0.8 https://ro.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-05-01T06:30:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-01T06:30:04+08:00 weekly 0.8 https://ro.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-05-25T20:09:48+08:00 weekly 0.8 https://ro.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2026-05-25T20:09:46+08:00 weekly 0.8 https://ro.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2023-03-31T10:50:17+08:00 weekly 0.9 https://ro.prisysbiotech.com/newslist-713596-1 2023-03-31T10:50:17+08:00 weekly 0.9 https://ro.prisysbiotech.com/newslist-713597-1 2024-07-29T16:30:53+08:00 weekly 0.9 https://ro.prisysbiotech.com/newslist-818681-1 2026-05-01T06:15:12+08:00 weekly 0.9 https://ro.prisysbiotech.com/newslist-17853619401024512-1 2023-03-31T10:50:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/meetprisys-sot2023-66085883.html 2023-03-31T10:50:25+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66085884.html 2023-03-31T10:50:24+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-sot2023-66085885.html 2023-03-31T10:50:25+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66085886.html 2026-09-01T21:36:32+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66085887.html 2026-09-01T21:36:46+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/gene-therapy-nhp-model-66085888.html 2026-09-01T21:36:38+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66085889.html 2023-03-31T10:50:26+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66085891.html 2026-09-01T21:36:53+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66085892.html 2026-09-01T21:36:50+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66085897.html 2026-09-01T21:33:09+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/gene-therapy-toxicology-66266569.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/world-parkinsons-disease-day-67237916.html 2026-09-01T21:33:15+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67237917.html 2026-09-01T21:33:13+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67237918.html 2026-09-01T21:33:16+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67237919.html 2026-09-01T21:33:19+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67237920.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67237921.html 2026-09-01T21:33:21+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67237922.html 2026-09-01T21:33:24+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67237923.html 2026-09-01T21:33:34+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68107632.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68107634.html 2026-09-01T21:33:31+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68107638.html 2026-09-01T21:33:35+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68107639.html 2026-09-01T21:33:36+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68311497.html 2026-09-01T21:33:37+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69148001.html 2026-09-01T21:33:44+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69148002.html 2026-09-01T21:33:40+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69148003.html 2026-09-01T21:33:38+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69148005.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69148007.html 2026-09-01T21:33:45+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69148588.html 2026-09-01T21:33:50+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309263.html 2026-09-01T21:33:55+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309264.html 2026-09-01T21:33:37+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309316.html 2026-09-01T21:33:36+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309360.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69656793.html 2026-07-22T01:03:19+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69658196.html 2026-09-01T21:33:53+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70945976.html 2026-09-01T21:33:57+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70945977.html 2026-09-01T21:33:54+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/0-70945982.html 2026-09-01T21:34:00+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70945983.html 2026-09-01T21:33:51+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70945986.html 2026-09-01T21:34:00+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70950234.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321100.html 2026-09-01T21:34:13+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321101.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321102.html 2026-09-01T21:34:46+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321103.html 2026-09-01T21:34:07+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321104.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72673820.html 2026-09-01T21:33:41+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001106.html 2026-09-01T21:33:34+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73525615.html 2026-09-01T21:33:36+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73525616.html 2026-07-22T01:41:41+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74286032.html 2026-09-01T21:33:42+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654558.html 2026-09-01T21:33:38+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74782795.html 2026-09-01T21:35:40+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75160609.html 2026-09-01T21:33:38+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75160610.html 2026-09-01T21:33:37+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76173433.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77051970.html 2026-09-01T21:33:39+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77696620.html 2024-11-12T09:22:58+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77696621.html 2026-09-01T21:35:48+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79186641.html 2026-09-01T21:35:51+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79186643.html 2026-09-01T21:35:46+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-asthma-model-79186644.html 2026-09-01T21:35:48+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79186645.html 2026-09-01T21:36:05+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79186646.html 2026-09-01T21:35:48+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410661.html 2024-11-12T09:22:55+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410663.html 2026-09-01T21:35:50+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410664.html 2026-09-01T21:33:39+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79527436.html 2026-09-01T21:35:49+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79527437.html 2026-09-01T21:35:56+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79527439.html 2026-09-01T21:33:42+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79527440.html 2026-09-01T21:33:42+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79527442.html 2026-09-01T21:36:09+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79527443.html 2026-09-01T21:35:56+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79527444.html 2026-09-01T21:35:58+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79527445.html 2026-09-01T21:36:00+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79527446.html 2026-09-01T21:35:59+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79527447.html 2026-09-01T21:36:10+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79527448.html 2026-09-01T21:36:00+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79527449.html 2026-09-01T21:35:58+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527450.html 2026-09-01T21:36:07+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79527451.html 2026-09-01T21:36:04+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79527452.html 2026-09-01T21:36:07+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79527453.html 2026-09-01T21:33:39+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79527454.html 2026-09-01T21:35:56+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79527455.html 2026-09-01T21:36:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79527456.html 2026-09-01T21:36:20+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79527457.html 2026-09-01T21:36:04+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79527458.html 2026-09-01T21:36:04+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79527459.html 2026-09-01T21:36:07+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79527460.html 2026-09-01T21:33:48+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/mrna-based-therapies-past-79527461.html 2026-09-01T21:36:05+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79527462.html 2026-09-01T21:33:42+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527463.html 2026-09-01T21:33:42+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527464.html 2026-09-01T21:36:03+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79527467.html 2026-09-01T21:36:09+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79527468.html 2026-09-01T21:36:00+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527469.html 2026-09-01T21:36:15+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79527470.html 2026-09-01T21:35:54+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79527471.html 2026-09-01T21:36:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79527472.html 2026-09-01T21:36:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79527473.html 2026-09-01T21:36:28+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79527474.html 2026-09-01T21:36:09+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/mrna-based-therapies-present-79527475.html 2026-09-01T21:36:25+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79527477.html 2026-09-01T21:36:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79527478.html 2026-09-01T21:33:42+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79527479.html 2026-09-01T21:33:45+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79527480.html 2026-09-01T21:36:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/significance-principles-and-requirements-of-79527481.html 2026-09-01T21:33:46+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79528311.html 2026-09-01T21:33:36+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pk-strategies-of-pdc-79528312.html 2026-09-01T21:36:05+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79528313.html 2026-09-01T21:33:55+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79528314.html 2026-09-01T21:33:42+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79528316.html 2026-09-01T21:34:02+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79528317.html 2026-09-01T21:33:48+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656477.html 2026-09-01T21:33:51+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120530.html 2026-09-01T21:33:56+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/convection-enhanced-delivery-81120531.html 2026-09-01T21:36:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120532.html 2026-09-01T21:33:56+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120533.html 2026-09-01T21:36:20+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/china-experimental-monkey-industry-81120534.html 2026-09-01T21:36:25+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/animal-models-of-human-diseases-81120535.html 2026-09-01T21:36:16+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/human-disease-animal-models-81120536.html 2026-09-01T21:36:16+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120537.html 2026-09-01T21:36:43+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120538.html 2026-09-01T21:34:20+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120540.html 2026-09-01T21:34:10+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120541.html 2026-09-01T21:34:05+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120542.html 2026-09-01T21:36:24+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/compartment-pk-model-81120927.html 2026-09-01T21:34:18+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82351148.html 2026-09-01T21:34:21+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82804124.html 2026-09-01T21:35:45+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82804125.html 2026-09-01T21:35:51+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82804126.html 2026-09-01T21:35:57+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82804128.html 2026-09-01T21:34:11+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82804130.html 2026-09-01T21:35:54+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82804131.html 2026-09-01T21:34:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82804136.html 2026-09-01T21:34:56+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82804139.html 2026-09-01T21:34:05+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82805388.html 2026-09-01T21:35:54+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83050843.html 2026-09-01T21:36:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83051925.html 2026-09-01T21:35:58+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83055108.html 2026-09-01T21:36:17+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84001398.html 2026-09-01T21:36:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84001399.html 2026-09-01T21:36:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84001400.html 2026-09-01T21:36:03+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84001401.html 2026-09-01T21:36:16+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84001403.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84001413.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84002184.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84002185.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84002191.html 2026-09-01T21:36:41+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17244178601763840.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17244211878814720.html 2026-09-01T21:36:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295638471959552.html 2026-09-01T21:36:07+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295638516786176.html 2026-09-01T21:36:09+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/animal-models-for-womens-health-17295638561612800.html 2026-07-22T01:41:53+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295638584009728.html 2026-07-22T01:42:21+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/membranous-nephropathy-model-17295638602736640.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295638615434240.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295638661374976.html 2026-09-01T21:36:05+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295638693389312.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295638727648256.html 2026-09-01T21:36:20+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295638773900288.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295638794249216.html 2026-07-22T01:41:59+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295638797607936.html 2026-09-01T21:36:04+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295638854935552.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295638863258624.html 2026-07-22T01:42:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295638952649728.html 2026-09-01T21:36:20+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295673847342080.html 2026-07-22T01:43:24+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299479124665344.html 2026-09-01T21:36:04+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374228944102400.html 2026-09-01T21:36:21+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374228966630400.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374229004772352.html 2026-07-22T01:42:08+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374229036180480.html 2026-07-22T01:42:33+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374229072192512.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374229111596032.html 2026-07-22T01:42:41+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374229131830272.html 2026-09-01T21:36:15+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374229170791424.html 2026-07-22T01:42:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374229319492608.html 2026-07-22T01:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374229340283904.html 2026-07-22T01:43:50+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374229533549568.html 2026-07-22T01:41:45+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374229536072704.html 2026-09-01T21:36:09+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17451761379304448.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17451761405256704.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17451761421706240.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17451761432323072.html 2026-07-22T01:41:46+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17451761519944704.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17451761556284416.html 2026-07-22T01:41:59+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17451761597965312.html 2026-09-01T21:36:15+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17451761650213888.html 2026-07-22T01:42:16+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/key-considerations-for-dosing-volume-17451761683588096.html 2026-09-01T21:36:18+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17451761829372928.html 2026-07-22T01:41:54+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17451762114405376.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17451762326594560.html 2025-08-23T21:22:50+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-copd-model-17499188998710272.html 2025-08-23T21:22:40+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17499189018928128.html 2026-09-01T21:36:20+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17499189019190272.html 2026-09-01T21:36:17+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17499189033772032.html 2025-08-23T21:23:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17499189190091776.html 2025-08-23T21:22:56+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17499189197693952.html 2025-09-14T20:46:25+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/brain-targeted-drug-delivery-17530304499360768.html 2025-09-14T20:46:35+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/the-importance-of-administration-volume-17530304651240448.html 2025-09-14T20:46:37+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530304706028544.html 2026-09-01T21:37:04+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530304738599936.html 2026-07-22T01:42:17+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530304751068160.html 2025-09-14T20:46:34+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530304761619456.html 2025-09-14T20:46:39+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530304790504448.html 2026-09-01T21:36:19+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538853234304000.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17557593965421568.html 2026-09-01T21:36:12+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625851150590976.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625851174528000.html 2026-09-01T21:36:17+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625851218928640.html 2026-07-22T01:41:58+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625851266311168.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625851294999552.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625851377509376.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625851380638720.html 2026-09-01T21:36:16+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625851433952256.html 2026-09-01T21:36:22+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625851495130112.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625851530404864.html 2026-07-22T01:42:33+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-renal-biopsy-17625851632067584.html 2026-07-22T01:42:13+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674614022185984.html 2026-07-22T01:43:45+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674614055511040.html 2025-12-25T19:15:58+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674614111544320.html 2025-12-25T19:16:12+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674614193513472.html 2025-12-25T19:26:25+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674622661583872.html 2025-12-25T19:26:35+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674622745633792.html 2025-12-25T19:26:30+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674622765982720.html 2025-12-25T19:26:24+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674622795883520.html 2026-09-01T21:36:25+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674622962443264.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724286638941184.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724286673134592.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724286679491584.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724286682932224.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724286695138304.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724286713586688.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724286742324224.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724286829093888.html 2026-01-29T22:05:26+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724312359740416.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724312906130432.html 2026-05-01T06:29:51+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17853633675682816.html 2026-05-01T06:30:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17853633681236992.html 2026-05-01T06:29:50+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17853633698817024.html 2026-05-01T06:29:42+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17853633728062464.html 2026-05-01T06:29:49+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17853633743037440.html 2026-05-01T06:29:51+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17853633757668352.html 2026-05-01T06:30:07+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17853633781605376.html 2026-05-01T06:29:45+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17853633804215296.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/evaluating-dmpk-properties-17853633815290880.html 2026-05-01T06:29:53+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17853633894097920.html 2026-05-01T06:29:48+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17853633899291648.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17853633903059968.html 2026-05-01T06:30:03+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17853633914151936.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17853633947689984.html 2026-05-01T06:29:39+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17853633967039488.html 2026-05-01T06:29:55+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17853634107925504.html 2026-07-22T05:41:59+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888417126278144.html 2026-07-22T05:42:16+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888417132078080.html 2026-05-25T20:09:56+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888417199170560.html 2026-05-25T20:10:16+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888417352295424.html 2026-05-25T20:10:28+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-models-translational-drug-development-17888417787864064.html 2026-07-22T05:42:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17946086762832896.html 2026-07-22T05:41:54+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17946087066477568.html 2026-07-22T05:24:48+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-heart-failure-model-17946087494329344.html 2026-07-22T05:42:21+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17946089369510912.html 2026-07-22T01:42:12+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17946107855545344.html 2026-07-22T05:42:15+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17946107933615104.html 2026-07-22T05:26:09+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17946107995890688.html 2026-07-22T05:24:59+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17946108039455744.html 2026-07-22T06:21:56+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17946108097700864.html 2026-07-22T01:41:59+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17969425800438784.html 2026-07-22T01:42:01+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17969425802159104.html 2026-07-22T01:42:09+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17969426012496896.html 2026-07-22T01:42:09+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17969426015511552.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17976601920119808.html 2026-08-23T11:16:28+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/webinar-nhp-behavioratlas-17976602663199744.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17976605786055680.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17976611168674816.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17976615058547712.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17976620758410240.html 2026-07-29T02:58:17+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17979412245734400.html 2026-08-02T02:16:50+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17985039499371520.html 2026-08-02T02:26:21+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/behavior-in-rhesus-17985048237024256.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990411993539584.html 2026-09-01T21:36:20+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993164133540864.html 2026-09-01T21:36:18+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003172174701568.html 2026-09-01T21:36:28+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003172435796992.html 2026-09-01T21:36:43+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015311196251136.html 2026-08-23T13:12:54+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015410315174912.html 2026-09-01T21:36:33+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021152863609856.html 2026-09-10T15:42:14+08:00 weekly 0.8 https://ro.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028065757651968.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-05-18T04:52:20+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/nhp-preclinical-studies-drug-development-significance-4028209.html 2026-06-08T05:14:11+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/cynomolgus-vs-rhesus-monkey-preclinical-research-4336037.html 2026-06-29T05:46:12+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/how-to-validate-a-pharmacokinetic-model-4620735.html 2026-07-22T04:46:23+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/what-is-the-impact-of-gender-on-pk-pharmacolog-4975100.html 2026-08-05T04:59:18+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/non-human-primate-accelerate-rheumatology-dev-5213201.html 2026-08-11T06:08:06+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/pharmacokinetic-study-design-drug-development-5320421.html 2026-08-21T04:34:25+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/minimum-sample-size-nhp-preclinical-studies-5531710.html 2026-09-04T06:29:31+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/how-does-rna-mediated-immune-response-impact-drug-pk-5778424.html 2026-06-15T05:05:32+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/pharmacodynamic-model-limitations-translational-nhp-studies-4439338.html 2026-06-05T04:40:58+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/mcao-nhp-model-post-stroke-brain-network-reorganization-4317703.html 2026-04-24T07:01:49+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/pk-pd-clinical-implications-3748810.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://ro.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html